Outset Medical (OM) Preferred Stock Liabilities (2019 - 2020)

Outset Medical's (OM) quarterly Preferred Stock Liabilities came in at $452.3 million in Q2 2020, little changed on a QoQ basis from $452.3 million in Q1 2020.

Outset Medical (OM) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

Outset Medical (OM) has 2 years of Preferred Stock Liabilities data on file, last reported at $452.3 million in Q2 2020.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $452.3 million in Q2 2020; TTM through Jun 2020 was $452.3 million, a N/A change from a year earlier, with the FY2019 full-year figure at $409.4 million, up 4.37% from the prior year.
  • Preferred Stock Liabilities for Q2 2020 stood at $452.3 million, roughly flat from $452.3 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for OM reached as high as $452.3 million in Q1 2020 and fell as low as $409.4 million in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Outset Medical 80,106.28 -286.56 Mn 12.10 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2020 452.27 Mn
Mar 31, 2020 452.27 Mn
Dec 31, 2019 409.45 Mn
Sep 30, 2019 409.45 Mn